Several studies have demonstrated a strong association between gut microbiome (e.g., Akkermansia and Bifidobacterium) and the anti‐PD‐1 immunotherapy response in many types of malignancies, including advanced NSCLC.7, 8. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.